Combo Provides ‘Broad Benefit’ Across NHL Subtypes
The combination of copanlisib plus rituximab led to a 48% reduction in the risk of disease progressi...
CD40 drug before surgery can benefit patients with early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD...
VEXAS: A Novel Rheumatologic, Hematologic Syndrome
Older men with a novel adult-onset, severe autoinf...
Bleeding Disorder Diagnoses Delayed by Years in Girls and Women
Diagnosis of bleeding disorders in girls and women...
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (T...